WuXi AppTec (WUXAY) Projected to Announce Quarterly Earnings on Monday

WuXi AppTec (OTCMKTS:WUXAY) is expected to be releasing its resultson Monday, July 27th. Analysts expect WuXi AppTec to announce earnings of $0.2321 per share and revenue of $1.9111 billion for the quarter.

WuXi AppTec (OTCMKTS:WUXAY) last posted its quarterly earnings data on Monday, April 27th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.18 by $0.05. The company had revenue of $1.82 billion during the quarter, compared to analyst estimates of $1.59 billion.

WuXi AppTec Trading Down 0.1%

Shares of WUXAY stock opened at $20.05 on Friday. The business’s 50 day simple moving average is $17.69 and its 200 day simple moving average is $16.10. WuXi AppTec has a one year low of $12.45 and a one year high of $21.35.

Wall Street Analysts Forecast Growth

Separately, Zacks Research upgraded shares of WuXi AppTec to a “hold” rating in a research note on Monday, April 13th. One research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy”.

About WuXi AppTec

WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. Headquartered in Shanghai and founded in 2000, the company provides end-to-end solutions that span drug discovery, development and manufacturing. Its offerings enable customers to accelerate the research and development process for small molecules, biologics, cell and gene therapies, as well as medical devices.

Key services include chemistry and biology discovery support, preclinical safety assessment, analytical and formulation development, clinical manufacturing, large-scale biomanufacturing, and quality testing.